Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
34,06 USD | -0,09% | -0,76% | -10,37% |
28/02 | Aandelen Inhibrx dalen na groter nettoverlies in Q4 | MT |
28/02 | Inhibrx, Inc. rapporteert resultaten voor het vierde kwartaal dat eindigde op 31 december 2023 | CI |
Vakgebied
Aantal werknemers: 169
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Biological Therapeutic Candidates
100,0
%
| 2 | 100,0 % | 2 | 100,0 % | -17,88% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 2 | 100,0 % | 2 | 100,0 % | -17,88% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Brendan Eckelman
FOU | Founder | 45 | 01-04-10 |
Mark Lappe
CEO | Chief Executive Officer | 57 | 01-04-10 |
Kelly Deck
DFI | Director of Finance/CFO | 44 | 01-10-18 |
Robert Boothroyd
CTO | Chief Tech/Sci/R&D Officer | - | 01-01-22 |
Vasily Andrianov
CTO | Chief Tech/Sci/R&D Officer | - | 01-01-21 |
Ashraf Amanullah
CTO | Chief Tech/Sci/R&D Officer | 56 | 01-08-18 |
Jeffrey Jensen
CTO | Chief Tech/Sci/R&D Officer | - | 01-01-20 |
Charbel Helaihel
SAM | Sales & Marketing | - | 01-02-23 |
David Kao
LAW | General Counsel | - | 28-10-21 |
Leah Pollema
LAW | General Counsel | - | 01-01-19 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Jon Kayyem
BRD | Director/Board Member | 60 | 01-04-18 |
Mark Lappe
CEO | Chief Executive Officer | 57 | 01-04-10 |
Kimberly Manhard
BRD | Director/Board Member | 64 | 01-06-20 |
Doug Forsyth
BRD | Director/Board Member | 55 | 01-04-18 |
Kristiina Vuori
BRD | Director/Board Member | 56 | 28-10-21 |
Brendan Eckelman
FOU | Founder | 45 | 01-04-10 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 47 392 447 | 33 862 578 ( 71,45 %) | 0 | 71,45 % |
Bedrijfsgegevens
Inhibrx, Inc.
11025 North Torrey Pines Road Suite 200
92037, La Jolla
+858 795 4220
http://www.inhibrx.comSector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-10,37% | 1,61 mld. | |
-2,31% | 103 mld. | |
+0,56% | 95,28 mld. | |
+1,69% | 22,15 mld. | |
-17,37% | 21,02 mld. | |
-9,30% | 18,15 mld. | |
-41,01% | 16,73 mld. | |
-14,85% | 16,05 mld. | |
+3,21% | 13,68 mld. | |
+33,54% | 12,17 mld. |
- Beurs
- Aandelen
- Koers INBX
- Onderneming Inhibrx, Inc.